Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clopidogrel 50mg vs 75mg in Cerebral Infarction
NCT00386191Phase 4Completed
- Sponsor
- Sanofi
- Start
- Sep 2006
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of clopidogrel in cerebral infarction (2 arms), sponsored by Sanofi. Primary endpoint: Incidence of bleeding adverse events at 52 weeks. Started Sep 2006; status: completed.
02
Drugs
clopidogrel
03
Conditions
cerebral infarction
Beyond the preview
Go deeper on NCT00386191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00386191.